Regular aspirin use fails to reduce risk of breast cancer -- NCI Journal.
This article was originally published in The Tan Sheet
Executive Summary
REGULAR ASPIRIN USE DOES NOT REDUCE THE RISK OF BREAST CANCER, Kathleen Egan et al. concluded in a prospective study published in the July 17 Journal of the National Cancer Institute. The Harvard researchers examined aspirin use and cancer incidence among women who participated in the 1980-1992 Nurses' Health Study.
You may also be interested in...
NSAID/Breast Cancer Study Joins Inconsistent Body Of Data On Relationship
Long-term, daily aspirin and ibuprofen use are linked to an increased risk of breast cancer in a recent epidemiologic study by Sarah Marshall, University of Southern California, et al.
NSAID/Breast Cancer Study Joins Inconsistent Body Of Data On Relationship
Long-term, daily aspirin and ibuprofen use are linked to an increased risk of breast cancer in a recent epidemiologic study by Sarah Marshall, University of Southern California, et al.
NSAID/Breast Cancer Study Joins Inconsistent Body Of Data On Relationship
Long-term, daily aspirin and ibuprofen use are linked to an increased risk of breast cancer in a recent epidemiologic study by Sarah Marshall, University of Southern California, et al.